These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28421320)

  • 1. Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model.
    Imai N; Suzuki M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishigami M; Hirooka Y; Ishikawa T; Goto H; Fujimoto T
    Histochem Cell Biol; 2017 Sep; 148(3):219-227. PubMed ID: 28421320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
    Imai N; Suzuki M; Hayashi K; Ishigami M; Hirooka Y; Abe T; Shioi G; Goto H; Fujimoto T
    PLoS One; 2015; 10(5):e0127114. PubMed ID: 25970332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH.
    Montefusco D; Jamil M; Maczis MA; Schroeder W; Levi M; Ranjit S; Allegood J; Bandyopadhyay D; Retnam R; Spiegel S; Cowart LA
    Mol Metab; 2022 Aug; 62():101523. PubMed ID: 35671973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
    Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
    Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
    Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
    Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
    Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
    J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
    J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
    Chen J; Hao Y; Xu P; Bian D; Han L; Wu X; Zhuang Z; Wang J; Luo Y
    Biochem Biophys Res Commun; 2023 Jul; 667():120-126. PubMed ID: 37216827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
    Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.
    Mesarwi OA; Shin MK; Bevans-Fonti S; Schlesinger C; Shaw J; Polotsky VY
    PLoS One; 2016; 11(12):e0168572. PubMed ID: 28030556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
    Lee SM; Muratalla J; Karimi S; Diaz-Ruiz A; Frutos MD; Guzman G; Ramos-Molina B; Cordoba-Chacon J
    Cell Mol Life Sci; 2023 Jan; 80(2):39. PubMed ID: 36629912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
    Loyer X; Paradis V; Hénique C; Vion AC; Colnot N; Guerin CL; Devue C; On S; Scetbun J; Romain M; Paul JL; Rothenberg ME; Marcellin P; Durand F; Bedossa P; Prip-Buus C; Baugé E; Staels B; Boulanger CM; Tedgui A; Rautou PE
    Gut; 2016 Nov; 65(11):1882-1894. PubMed ID: 26338827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.